Related Experiment Video
Updated: Jan 16, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Ruvidar®-An Effective Anti-Herpes Simplex Virus Agent.
Kevin M Coombs1, Roger DuMoulin-White2, Arkady Mandel2
1Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.
Ruvidar® shows promise in inhibiting Herpes Simplex Virus type 1 (HSV-1) replication. This novel compound is effective alone and in combination with existing antivirals, even against resistant strains.
Area of Science:
- Virology
- Antiviral Research
- Drug Discovery
Background:
- Herpes Simplex Viruses (HSVs) are widespread, causing lifelong infections.
- Current treatments like acyclovir target viral DNA synthesis but face resistance.
- Ruvidar® is a small molecule with previously demonstrated broad-spectrum antiviral activity.
Purpose of the Study:
- To evaluate Ruvidar®'s efficacy against HSV-1 replication in cell cultures.
- To assess Ruvidar®'s effectiveness in combination with acyclovir and metformin.
- To investigate Ruvidar®'s activity against acyclovir-resistant HSV-1 mutants.
Main Methods:
- HSV-1 replication was studied in Vero and U251 glioblastoma cells.
- Ruvidar® was tested alone and in combination with acyclovir and metformin.
- Experiments were conducted without light activation to simulate deep tissue conditions.
Main Results:
- Ruvidar® significantly inhibited HSV-1 replication at low concentrations.
- Combinational therapy with Ruvidar® showed additive and synergistic effects.
- Ruvidar® was effective against acyclovir-resistant HSV-1 and protected cells from cytopathology.
Conclusions:
- Ruvidar® is a potent inhibitor of HSV-1 replication.
- Ruvidar® offers a promising therapeutic option, particularly in combination therapies.
- Ruvidar® demonstrates efficacy against resistant HSV-1 strains and cytopathic effects.
Related Concept Videos
Retrovirus Life Cycles
Subviral Agents
Retroviruses
Viruses with RNA Genomes
Size and Structure of Viral Genomes
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

